AyuVis Research
Suchismita Acharya is the founder and CEO of AyuVis Research. Suchismita has a background in pre-clinical drug discovery and development, and has consulted on SBIR/STTR grant proposals and patent drafting. Her expertise lies in sepsis and anti-bacterial therapies.
Suchismita Acharya received their PhD in Organic Chemistry from the Indian Institute of Chemical Technology in Hyderabad. Suchismita then pursued a Post-Doctoral Fellowship in Organic/Medicinal Chemistry at UT Southwestern Medical Center. Suchismita also holds a MS in Chemistry from Utkal University.
Some individuals on their team include Dennis Dean - Head of CMC, Dale Christensen - Director of Early Development, and David Riley - Chief Medical Officer.
This person is not in any offices
AyuVis Research
AyuVis Research, Inc. is a start-up biopharmaceutical company in the preclinical stage of drug development. They focus on developing New Molecular Entities (NME)/ New Technologies as immune-modulating, anti-infective and anti-inflammatory drugs.